Management of venous thromboembolism with non-vitamin K oral anticoagulants: A review for nurse practitioners and pharmacists.

Journal of the American Association of Nurse Practitioners
Michelle SchmergeCarol Kline

Abstract

Venous thromboembolism (VTE), comprising deep-vein thrombosis and pulmonary embolism, is associated with significant morbidity and mortality. Non-vitamin K oral anticoagulants (NOACs), including apixaban, betrixaban, dabigatran, edoxaban, and rivaroxaban, are as effective and safe as vitamin K antagonists (VKAs) for primary prophylaxis, treatment, and/or secondary prevention of VTE and present significant advantages in convenience of use. This review provides guidance to nurse practitioners (NPs) and pharmacists on NOAC usage for the management of VTE and examines how traditional anticoagulation clinics can adapt to cater to patients on NOACs. A review of the scientific literature pertaining to treatment guideline recommendations, large randomized clinical trials, and real-world evidence studies related to VTE management was conducted. With current data suggesting that NOACs may present as better alternatives over VKAs for the management of VTE, comprehensively educating NPs and pharmacists can help incorporate these agents in their clinical practice. Repurposing anticoagulation clinics, led by well-informed NPs and pharmacists, will allow effective integration and optimal management of patients with VTE taking NOACs as well as...Continue Reading

References

Dec 8, 2009·The New England Journal of Medicine·Sam SchulmanUNKNOWN RE-COVER Study Group
Oct 26, 2012·Thrombosis·Sophie TestaEmilia Cancellieri
Dec 12, 2012·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN AMPLIFY-EXT Investigators
Feb 22, 2013·The New England Journal of Medicine·Sam SchulmanUNKNOWN RE-SONATE Trial Investigators
Jul 3, 2013·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN AMPLIFY Investigators
Aug 24, 2013·Expert Opinion on Investigational Drugs·Michael PalladinoLynda Thomson
Dec 18, 2013·Circulation·Sam SchulmanUNKNOWN RE-COVER II Trial Investigators
Jun 23, 2015·The New England Journal of Medicine·Charles V PollackJeffrey I Weitz
Oct 22, 2015·Journal of Nursing Care Quality·Lee Hilary GoldsteinWalid Saliba
Jan 19, 2016·Journal of Thrombosis and Thrombolysis·John A HeitRichard H White
Jan 19, 2016·Journal of Thrombosis and Thrombolysis·Allison E BurnettJack Ansell
Mar 5, 2016·Circulation. Cardiovascular Quality and Outcomes·Geoffrey D BarnesJames B Froehlich
May 28, 2016·The New England Journal of Medicine·Alexander T CohenUNKNOWN APEX Investigators
Jun 3, 2016·Journal of Cardiovascular Pharmacology and Therapeutics·Lee Joseph, John R Bartholomew
Sep 23, 2016·Thrombosis and Haemostasis·Jeffrey I WeitzAjay K Kakkar
Oct 4, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Emanuel RaschiFabrizio De Ponti
Oct 22, 2016·Thrombosis Journal·Lai Heng Lee
Feb 9, 2017·Circulation·Amish N RavalUNKNOWN American Heart Association Clinical Pharmacology Subcommittee of the Acute Cardiac Care and General Cardiology Committee of
Mar 25, 2017·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Emily AshjianGeoffrey D Barnes
Jun 3, 2017·Clinical Medicine : Journal of the Royal College of Physicians of London·Carolyn M Millar, Mike A Laffan
Aug 19, 2017·Journal of Vascular Surgery. Venous and Lymphatic Disorders·Anand BrahmandamCassius Iyad Ochoa Chaar
Oct 19, 2017·BMJ : British Medical Journal·Min JunUNKNOWN Canadian Network for Observational Drug Effect Studies (CNODES) Investigators
Nov 18, 2017·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Kelu HouXiangli Cui
Dec 24, 2017·Journal of Thrombosis and Thrombolysis·Katelyn W SylvesterJean M Connors

❮ Previous
Next ❯

Citations

Dec 18, 2020·JAAPA : Official Journal of the American Academy of Physician Assistants·Jenna Hill SewellMiroslav Sarac

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Respiratory Review : an Official Journal of the European Respiratory Society
Massimo Franchini, Pier Mannuccio Mannucci
Advances in Therapy
Thomas Vanassche, Peter Verhamme
© 2022 Meta ULC. All rights reserved